Apo-varenicline

Varenicline


Apotex Corp
Human Prescription Drug
NDC 60505-4765
Apo-varenicline also known as Varenicline is a human prescription drug labeled by 'Apotex Corp'. National Drug Code (NDC) number for Apo-varenicline is 60505-4765. This drug is available in dosage form of Tablet, Film Coated. The names of the active, medicinal ingredients in Apo-varenicline drug includes Varenicline Tartrate - .5 mg/1 . The currest status of Apo-varenicline drug is Active.

Drug Information:

Drug NDC: 60505-4765
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Apo-varenicline
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Varenicline
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Apotex Corp
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet, Film Coated
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:VARENICLINE TARTRATE - .5 mg/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 16 Jul, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 31 Mar, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 29 Dec, 2025
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Apotex Corp
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:636671
636676
749289
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0300690469560
0360505476664
0360505476558
0360505476657
0360505476701
UPC stands for Universal Product Code.
UNII:82269ASB48
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Cholinergic Agonists [MoA]
Cholinergic Receptor Agonist [EPC]
Partial Cholinergic Nicotinic Agonist [EPC]
Partial Cholinergic Nicotinic Agonists [MoA]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
60505-4765-556 TABLET, FILM COATED in 1 BOTTLE (60505-4765-5)16 Jul, 202131 Mar, 2025No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Apo-varenicline varenicline apo-varenicline apo-varenicline microcrystalline cellulose anhydrous dibasic calcium phosphate magnesium stearate hypromellose 2910 (5 mpa.s) hydroxypropyl cellulose (110000 wamw) triacetin titanium dioxide varenicline tartrate varenicline apo;var;0;5 capsule-shaped apo-varenicline apo-varenicline microcrystalline cellulose anhydrous dibasic calcium phosphate magnesium stearate hypromellose 2910 (5 mpa.s) hydroxypropyl cellulose (110000 wamw) triacetin titanium dioxide varenicline tartrate varenicline fd&c blue no. 2 capsule-shaped apo;var;1 apo-varenicline varenicline varenicline tartrate varenicline microcrystalline cellulose anhydrous dibasic calcium phosphate magnesium stearate hypromellose 2910 (5 mpa.s) hydroxypropyl cellulose (110000 wamw) triacetin titanium dioxide capsule-shaped apo;var;0;5 apo-varenicline varenicline microcrystalline cellulose anhydrous dibasic calcium phosphate magnesium stearate hypromellose 2910 (5 mpa.s) hydroxypropyl cellulose (110000 wamw) triacetin titanium dioxide varenicline tartrate varenicline fd&c blue no. 2 capsule-shaped apo;var;1 chantix0.5mg56count chantix0.5mgimage chantix1mg56count chantix1mgimage chantixcontinuationpack chantixstarterpack containerlabel0.5mg56count containerlabel1mg56count vareniclinecontinuationpack vareniclinestarterpack apo0.5mgimage apo1mgimage barcode1.jpg barcode2.jpg barcode3.jpg barcode4.jpg chantixstructure.jpg apotexstructure.jpg pfizerlogo.jpg chantixfigure1.jpg chantixfigure2.jpg chantixfigure3.jpg chantixmed1.jpg chantixmed2.jpg chantixmed3.jpg chantixmed4.jpg chantixstorage.jpg chantixtable1.jpg chantixtable2.jpg chantixtable3.jpg chantixtable4.jpg chantixtable5.jpg chantixtable6.jpg chantixtable7.jpg chantixtable8.jpg chantixtable9.jpg chantixtable10.jpg chantixtable11.jpg chantixtable12.jpg chantixtable13.jpg chantixtable14.jpg chantixtable15.jpg chantixtable16.jpg chantixtable17.jpg chantixtable18.jpg chantixtable19.jpg chantixtabledose.jpg chantixmed5.jpg apofigure2.jpg apofigure3.jpg apomed1.jpg apomed2.jpg apomed3.jpg apotable.jpg apotable1.jpg apotable5.jpg apotable6.jpg apotable7.jpg apotable8.jpg apotable8a.jpg apotable9.jpg apotable11.jpg apotable12.jpg apotable13.jpg apotable14.jpg apodose1.jpg

Warnings and Cautions:

Warnings and precautions before you use apo-varenicline talk to your healthcare provider if you: - have experienced depression or any other mental health problems. your healthcare provider will monitor you for new or worsened emotional or behavioral problems during treatment with apo-varenicline. - have any problems with your kidneys, as you may need a lower dose of apo-varenicline. - have heart or blood vessel (cardiovascular) problems. - have a history of seizures. - have any other medical conditions. - are pregnant, are breastfeeding or plan to become pregnant (see “pregnancy” and “breastfeeding” below). - have diabetes. apo-varenicline can potentially affect your blood sugar regulation, and you may need to monitor your blood sugar more often. if you notice changes, discuss this with your healthcare provider. the effects of changes in your body resulting from stopping smoking, with or without treatment with apo-varenicline, may alter the way other drugs work. tel
l your healthcare provider about all your other medicines, including prescription and nonprescription medicines, vitamins and herbal supplements. especially, tell your healthcare provider if you take: insulin asthma medicines (theophylline) blood thinner (warfarin) as an adjustment of the dose of these medicines may be necessary once you are smoke-free. mental health symptoms see “what is the most important information i should know about apo-varenicline?” pregnancy talk to your healthcare provider if you are pregnant or planning to become pregnant. you should not take apo-varenicline while you are pregnant. it is unknown if apo-varenicline will harm your unborn baby. it is best to stop smoking before you get pregnant. breastfeeding you should ask your healthcare provider for advice before taking any medication, including apo-varenicline, if you are breastfeeding, as the medicine may pass into breast milk. apo-varenicline is not recommended for use in children under 18 years of age. accidental injury, including while driving, operating machinery do not engage in potentially hazardous tasks, such as driving a car or operating dangerous machines, until you know how apo-varenicline may affect you. in some cases, people have reported sleepiness, dizziness, blackouts, seizures or difficulty concentrating while driving. seizures tell your healthcare provider if you have experienced seizures or have epilepsy before you start apo-varenicline treatment. some people have reported seizures while taking varenicline, both with and without a history of seizures. heart or stroke events new or worse heart or blood vessel (cardiovascular) problems have been reported in people taking varenicline, primarily in those who already have cardiovascular problems. from the information available to date, it is not possible to determine whether apo-varenicline increases the risk of heart or stroke events. tell your healthcare provider if you have any changes in cardiovascular symptoms during treatment with apo-varenicline. get emergency medical help right away if you have symptoms of a heart attack, including any of the following: chest discomfort (uncomfortable pressure, squeezing, fullness or pain) that lasts more than a few minutes, or that goes away and comes back. pain or discomfort in one or both arms, back, neck, jaw or stomach. shortness of breath, sweating, nausea, vomiting, or feeling lightheaded associated with chest discomfort. get emergency medical help right away if you have symptoms of a stroke, including any of the following: weakness - sudden loss of strength or sudden numbness in the face, arm or leg even if temporary. trouble speaking - sudden difficulty speaking or understanding or sudden confusion, even if temporary. vision problems - sudden trouble with vision, even if temporary. headache - sudden severe and unusual headache. dizziness - sudden loss of balance, especially with any of the above signs. sleepwalking sleepwalking has been reported in patients taking apo-varenicline, and may sometimes lead to behaviour that is harmful to you or other people or property. stop taking apo-varenicline and tell your healthcare provider if you start sleepwalking.

Adverse Reactions:

Side effects and what to do about them whether you are taking medication to stop smoking or not, the following are symptoms you may feel: depressed, short-tempered, frustrated or angry, nervous, impatient; have difficulty concentrating. your appetite may increase, and you may gain some weight. like all medicines, apo-varenicline can cause side effects, although not everybody gets them. the common side effects are mostly mild to moderate and these usually occur in the first weeks of treatment. some of the most common side effects you should be aware of include: nausea, vomiting trouble sleeping headache abnormal dreams (vivid, unusual, or increased dreaming; rarely may include nightmares) sleepiness, tiredness, dizziness constipation, diarrhea, gas mental health problems see “what is the most important information i should know about apo-varenicline?” stop taking apo-varenicline if you experience severe or unusual feelings of agitation, aggression, depressed mood, hostility, h
allucinations, or if you have thoughts of self-harm or harm to others. tell your healthcare provider about your symptoms. allergic reactions some people have allergic reactions to apo-varenicline. some of these allergic reactions can be life-threatening and include: swelling of the face, mouth (lips, gums, tongue), and throat can cause trouble breathing. if you have these symptoms, stop taking apo-varenicline and seek immediate emergency medical attention. serious skin reactions some people can have serious skin reactions while taking apo-varenicline. these can include rash, swelling, redness, and peeling of the skin. some of these reactions can become life-threatening. if you have a rash with peeling skin, or blistering of the mouth, around the eyes or genitals, stop taking apo-varenicline and seek immediate emergency medical attention. serious side effects, how often they happen and what to do about them symptom/effect talk to your healthcare professional stop taking drug and get immediate medical help only if severe in all cases rare allergic reaction redness, itching or swelling of your skin, hives, burning, stinging, swelling of the neck area, or any difficulty with breathing, not present before using this medicine √ rare serious skin reactions peeling of the skin, or rash combined with blisters around the mouth, eyes or genitals. √ rare mental health problems √ √ (if severe, or if involves potential for harm to self or others) unknown heart attack: chest pain often associated with left shoulder or jaw pain, feeling of constriction around chest and sweating √ unknown stroke: weakness and/or loss of sensation of limbs or face, difficulty speaking, clumsiness, visual loss √ unknown seizures : loss of consciousness with uncontrollable shaking (convulsion) √ unknown sleepwalking √ (and stop taking apo-varenicline) this is not a complete list of side effects. for any unexpected effects while taking apo-varenicline, contact your doctor or pharmacist.

Adverse Reactions Table:

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom/effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
RareAllergic reaction redness, itching or swelling of your skin, hives, burning, stinging, swelling of the neck area, or any difficulty with breathing, not present before using this medicine
RareSerious skin reactions peeling of the skin, or rash combined with blisters around the mouth, eyes or genitals.
RareMental Health Problems√ (if severe, or if involves potential for harm to self or others)
UnknownHeart attack: chest pain often associated with left shoulder or jaw pain, feeling of constriction around chest and sweating
UnknownStroke: weakness and/or loss of sensation of limbs or face, difficulty speaking, clumsiness, visual loss
UnknownSeizures: Loss of consciousness with uncontrollable shaking (convulsion)
UnknownSleepwalking√ (and stop taking APO-VARENICLINE)

Spl Patient Package Insert:

Patient package insert part iii: consumer information pr apo-varenicline varenicline tablets 0.5 mg and 1 mg varenicline (as varenicline tartrate) read this information each time you refill your prescription in case new information has been added. this leaflet is part iii of a three-part "product monograph" published when apo-varenicline was approved for sale in canada and is designed specifically for consumers. this leaflet is a summary and will not tell you everything about apo-varenicline . contact your doctor or pharmacist if you have any questions about the drug. what is the most important information i should know about apo-varenicline ? when you try to quit smoking, with or without apo-varenicline, you may have symptoms that may be due to nicotine withdrawal, including the urge to smoke depressed mood trouble sleeping irritability frustration anger feeling anxious difficulty concentrating restlessness decreased heart rate increased appetite or weight gain. some people have even
experienced suicidal thoughts when trying to quit smoking without medication. sometimes quitting smoking can lead to worsening of mental health problems that you already have, such as depression. mental health problems some people have had serious side effects while taking apo-varenicline to help them quit smoking, including changes in behavior or thinking, hostility, agitation, aggression, depressed mood, or suicidal thoughts or actions. these symptoms have occurred in people with previous mental health problems, as well as in those with no previous history. for some people, these symptoms began when they started taking apo-varenicline while for others, they began after several weeks of treatment, or shortly after stopping apo-varenicline. before taking any quit-smoking treatment, including apo-varenicline, tell your healthcare provider (doctor, pharmacist or nurse): if you have ever had depression or other mental health problems; about any concerning symptoms you had during other times you tried to quit smoking, with or without medication. inform your friends and family members of your quit attempt with apo-varenicline and ask for their support and help in monitoring for any changes in behavior or thinking that are not normal. drinking alcohol may increase the risk of having mental health problems during your treatment with apo-varenicline. patients with history of mental health problems (e.g. depression, anxiety, schizophrenia): if you have had mental health problems before taking apo-varenicline, your healthcare provider will monitor you while you try to quit smoking with apo-varenicline. if you develop worsened or new symptoms, talk to your healthcare provider right away because changing the dose (of apo-varenicline or other medications) may make a difference. all patients/general: if you have thoughts, moods or behaviours that are severe, concerning or very abnormal for you, stop taking apo-varenicline right away, seek medical help, and tell your healthcare provider about your symptoms. in many people, these symptoms went away after stopping apo-varenicline, but not in all. it is important for you to follow up with your healthcare provider until your symptoms go away. allergic reactions some people can have allergic reactions to apo-varenicline. some of these allergic reactions can be life-threatening and include: swelling of the face, mouth, and throat that can cause trouble breathing. if you have these symptoms, stop taking apo-varenicline and seek immediate emergency medical attention. serious skin reactions some people can have serious skin reactions while taking apo-varenicline. these can include rash, swelling, redness, and peeling of the skin. some of these reactions can become life-threatening. if you have a rash with peeling skin or blisters in your mouth, around the eyes or genitals, stop taking apo-varenicline and seek immediate emergency medical attention. about this medication what the medication is used for: apo-varenicline is a prescription medicine which is used in combination with supportive counselling to help motivated adults stop smoking. what it does: apo-varenicline can help to relieve the craving and withdrawal symptoms associated with stopping smoking. apo-varenicline does not contain nicotine, but it has been shown to affect the nicotine receptor in the brain that is thought to be most related to smoking addiction. apo-varenicline can affect this receptor in two opposite ways: it acts like a weaker version of nicotine, and also blocks nicotine from getting to the receptor because it binds more tightly. although it is thought that this may be, in part, how apo-varenicline works, it is not known exactly how the drug works in people. when it should not be used: do not take apo-varenicline if you: - are allergic (hypersensitive) to varenicline tartrate or any of the other ingredients of apo-varenicline (see list below of non-medicinal ingredients). - are using nicotine replacement therapy, such as patches, gum or inhaler. the combination of apo-varenicline and nicotine replacement therapy is not expected to improve your chances of quitting, and may result in more side effects than with apo-varenicline alone. what dosage forms it comes in: apo-varenicline is available as film-coated tablets. the 0.5 mg tablets are white and the 1 mg tablets are blue. warnings and precautions before you use apo-varenicline talk to your healthcare provider if you: - have experienced depression or any other mental health problems. your healthcare provider will monitor you for new or worsened emotional or behavioral problems during treatment with apo-varenicline. - have any problems with your kidneys, as you may need a lower dose of apo-varenicline. - have heart or blood vessel (cardiovascular) problems. - have a history of seizures. - have any other medical conditions. - are pregnant, are breastfeeding or plan to become pregnant (see “pregnancy” and “breastfeeding” below). - have diabetes. apo-varenicline can potentially affect your blood sugar regulation, and you may need to monitor your blood sugar more often. if you notice changes, discuss this with your healthcare provider. the effects of changes in your body resulting from stopping smoking, with or without treatment with apo-varenicline, may alter the way other drugs work. tell your healthcare provider about all your other medicines, including prescription and nonprescription medicines, vitamins and herbal supplements. especially, tell your healthcare provider if you take: insulin asthma medicines (theophylline) blood thinner (warfarin) as an adjustment of the dose of these medicines may be necessary once you are smoke-free. mental health symptoms see “what is the most important information i should know about apo-varenicline?” pregnancy talk to your healthcare provider if you are pregnant or planning to become pregnant. you should not take apo-varenicline while you are pregnant. it is unknown if apo-varenicline will harm your unborn baby. it is best to stop smoking before you get pregnant. breastfeeding you should ask your healthcare provider for advice before taking any medication, including apo-varenicline, if you are breastfeeding, as the medicine may pass into breast milk. apo-varenicline is not recommended for use in children under 18 years of age. accidental injury, including while driving, operating machinery do not engage in potentially hazardous tasks, such as driving a car or operating dangerous machines, until you know how apo-varenicline may affect you. in some cases, people have reported sleepiness, dizziness, blackouts, seizures or difficulty concentrating while driving. seizures tell your healthcare provider if you have experienced seizures or have epilepsy before you start apo-varenicline treatment. some people have reported seizures while taking varenicline, both with and without a history of seizures. heart or stroke events new or worse heart or blood vessel (cardiovascular) problems have been reported in people taking varenicline, primarily in those who already have cardiovascular problems. from the information available to date, it is not possible to determine whether apo-varenicline increases the risk of heart or stroke events. tell your healthcare provider if you have any changes in cardiovascular symptoms during treatment with apo-varenicline. get emergency medical help right away if you have symptoms of a heart attack, including any of the following: chest discomfort (uncomfortable pressure, squeezing, fullness or pain) that lasts more than a few minutes, or that goes away and comes back. pain or discomfort in one or both arms, back, neck, jaw or stomach. shortness of breath, sweating, nausea, vomiting, or feeling lightheaded associated with chest discomfort. get emergency medical help right away if you have symptoms of a stroke, including any of the following: weakness - sudden loss of strength or sudden numbness in the face, arm or leg even if temporary. trouble speaking - sudden difficulty speaking or understanding or sudden confusion, even if temporary. vision problems - sudden trouble with vision, even if temporary. headache - sudden severe and unusual headache. dizziness - sudden loss of balance, especially with any of the above signs. sleepwalking sleepwalking has been reported in patients taking apo-varenicline, and may sometimes lead to behaviour that is harmful to you or other people or property. stop taking apo-varenicline and tell your healthcare provider if you start sleepwalking. interactions with this medication drinking alcohol during treatment with apo-varenicline may increase the risk of mental health symptoms. reported experiences include: unusual or sometimes aggressive behavior; more intoxicated than expected from the amount of alcohol; no memory of things that have happened. use of apo-varenicline with other therapies for smoking-cessation: the safety and benefits of taking apo-varenicline in combination with other medicines for stopping smoking have not been studied. taking apo-varenicline in combination with other smoking-cessation therapies (e.g., nicotine replacement therapy) is therefore not recommended. using apo-varenicline in combination with nicotine replacement therapies (e.g., patch gum or inhaler) is not likely to increase your chances of quitting smoking, and it may result in more side effects than with apo-varenicline alone. proper use of this medication you are more likely to stop smoking if you are motivated to stop. your healthcare provider can provide advice, support and sources of further information to help ensure your attempt to stop smoking is successful. to increase the chances of success, apo-varenicline should be used in combination with supportive counselling as recommended by your healthcare provider. varenicline was used in combination with supportive counselling in the clinical trials. at any time, you can also call government-funded toll-free provincial quit lines, to speak to a knowledgeable and supportive specialist; these phone numbers are available on the health canada website. always take apo-varenicline exactly as your healthcare provider has told you. you should check with your healthcare provider if you are not sure. remember: this medication has been prescribed specifically for you. do not give it to anyone else. setting your quit date: starting treatment before your quit date lets apo-varenicline build up in your body. you can keep smoking until your quit date. there are three ways to set your quit date when using apo-varenicline. talk to your healthcare provider about which way is best for you: fixed quit approach: set a quit date when you will stop smoking. start taking apo-varenicline 8 to 14 days (1 to 2 weeks) before your quit date. you should take apo-varenicline for 12 weeks. after 12 weeks of treatment, your healthcare provider may recommend an additional 12 weeks of treatment. or flexible quit approach: start taking apo-varenicline, then quit smoking between day 8 and day 35 after the start of your treatment (i.e. between weeks 2 and 5). you should take apo-varenicline for 12 weeks. after 12 weeks of treatment, your healthcare provider may recommend an additional 12 weeks of treatment. or gradual quit approach: start taking apo-varenicline and reduce smoking with a goal to quit smoking by end of 12 weeks of treatment. for example, reduce smoking by half by the 4 th week, another half by the 8 th week (down to 25%) and then quit by the end of the 12 th week. you may quit any time before the end of 12 weeks of treatment, if you are able to. continue treatment for an additional 12 weeks for a total of 24 weeks. write down, and keep in a visible or convenient place (for example on the fridge or on the apo-varenicline pack), the date that you started apo- varenicline, your quit date, and the date to stop taking apo-varenicline. make sure that you try to stop smoking on your quit date. if you slip-up and smoke after that target date, keep trying. some people need a few weeks on apo-varenicline for it to work best. dosing options: apo-varenicline should be taken after eating and with a full glass of water. regardless of which dose is prescribed, the first week on apo-varenicline is the same, and is described in the following table: week 1 dosing schedule: day dose day 1 to 3 take one white apo-varenicline 0.5 mg tablet once a day. day 4 to 7 take one white apo-varenicline 0.5 mg tablet twice a day, once in the morning and once in the evening, at about the same time each day. after the first week, your healthcare provider may recommend to stay at 0.5 mg twice a day (option 1) or go up to 1 mg twice a day (option 2). week 2 (day 8) to the end of treatment option 1: continue on 0.5 mg twice a day day dose day 8 - end of treatment 0.5 mg twice a day: continue to take one white apo-varenicline 0.5 mg pill in the morning, and one in the evening, at about the same time each day or option 2: start taking 1 mg twice a day day dose day 8 - end of treatment 1 mg twice a day: take one light blue apo-varenicline 1 mg pill in the morning, and one in the evening, at about the same time each day. the maximum dose of apo-varenicline is 1 mg twice a day. based on the limited data available, the two doses do not appear different in terms of either quit rates, or rates of serious mental health side effects (your healthcare provider can provide more information). discussion with your healthcare provider is important in order to choose the dose that is best for you. if needed, the dose can be changed depending on how well you tolerate apo-varenicline and how effective your healthcare provider and you consider it is in helping you quit smoking. your healthcare provider will help decide what dose is right for you. your healthcare provider may recommend to gradually lower the dose at the end of the treatment period rather than stopping abruptly. can i smoke while taking apo-varenicline? you can keep smoking prior to your quit date. smoking after your quit date will reduce your chance of breaking your smoking addiction. some people have reported a change in the taste of cigarettes after starting apo-varenicline. overdose: if you think you have taken too much apo-varenicline, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms. missed dose: do not take a double dose to make up for a forgotten tablet. it is important that you take apo-varenicline regularly at the same time each day. if you forget to take a dose, take it as soon as you remember, as long as it is within a few hours of the missed dose. if it has been longer than a few hours since the missed dose, or if you do not remember whether you took a dose or not, then skip that dose, and wait to take the next dose at the correct time. if you have any further questions on the use of this product, ask your healthcare provider. side effects and what to do about them whether you are taking medication to stop smoking or not, the following are symptoms you may feel: depressed, short-tempered, frustrated or angry, nervous, impatient; have difficulty concentrating. your appetite may increase, and you may gain some weight. like all medicines, apo-varenicline can cause side effects, although not everybody gets them. the common side effects are mostly mild to moderate and these usually occur in the first weeks of treatment. some of the most common side effects you should be aware of include: nausea, vomiting trouble sleeping headache abnormal dreams (vivid, unusual, or increased dreaming; rarely may include nightmares) sleepiness, tiredness, dizziness constipation, diarrhea, gas mental health problems see “what is the most important information i should know about apo-varenicline?” stop taking apo-varenicline if you experience severe or unusual feelings of agitation, aggression, depressed mood, hostility, hallucinations, or if you have thoughts of self-harm or harm to others. tell your healthcare provider about your symptoms. allergic reactions some people have allergic reactions to apo-varenicline. some of these allergic reactions can be life-threatening and include: swelling of the face, mouth (lips, gums, tongue), and throat can cause trouble breathing. if you have these symptoms, stop taking apo-varenicline and seek immediate emergency medical attention. serious skin reactions some people can have serious skin reactions while taking apo-varenicline. these can include rash, swelling, redness, and peeling of the skin. some of these reactions can become life-threatening. if you have a rash with peeling skin, or blistering of the mouth, around the eyes or genitals, stop taking apo-varenicline and seek immediate emergency medical attention. serious side effects, how often they happen and what to do about them symptom/effect talk to your healthcare professional stop taking drug and get immediate medical help only if severe in all cases rare allergic reaction redness, itching or swelling of your skin, hives, burning, stinging, swelling of the neck area, or any difficulty with breathing, not present before using this medicine √ rare serious skin reactions peeling of the skin, or rash combined with blisters around the mouth, eyes or genitals. √ rare mental health problems √ √ (if severe, or if involves potential for harm to self or others) unknown heart attack: chest pain often associated with left shoulder or jaw pain, feeling of constriction around chest and sweating √ unknown stroke: weakness and/or loss of sensation of limbs or face, difficulty speaking, clumsiness, visual loss √ unknown seizures : loss of consciousness with uncontrollable shaking (convulsion) √ unknown sleepwalking √ (and stop taking apo-varenicline) this is not a complete list of side effects. for any unexpected effects while taking apo-varenicline, contact your doctor or pharmacist. how to store it store apo-varenicline at room temperature (15°c to 30°c). keep out of the reach and sight of children. reporting side effects you can report any suspected side effects associated with the use of health products to health canada by: • visiting the web page on adverse reaction reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or • calling toll-free at 1-866-234-2345. note: contact your health professional if you need information about how to manage your side effects. the canada vigilance program does not provide medical advice. more information if you want more information about apo-varenicline: talk to your healthcare professional find the full product monograph that is prepared for healthcare professionals and includes this consumer information by visiting the health canada website ( https://health-products.canada.ca/dpd-bdpp/index-eng.jsp ). find the consumer information on the manufacturer’s website ( http://www.apotex.ca/products ) or by calling 1-800-667-4708. this leaflet was prepared by apotex inc., toronto, ontario m9l 1t9. last revised: april 09, 2019

Package Label Principal Display Panel:

Principal display panel apo-varenicline tablets 0.5 mg 56 tablets bottle label 60505-4765

Principal display panel apo-varenicline tablets 1 mg 56 tablets bottle label 60505-4766-6

Principal display panel apo-varenicline tablets starter blister pack 0.5 mg - 11 tablets 1 mg - 42 tablets 60505-4767-0

Principal display panel apo-varenicline tablets continuation blister pack 1 mg 60505-4766-5


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.